Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Inflammation01:38

Inflammation

Overview
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Nuclear Pore Complexes with Exceptionally Selective Shuttle-Cargo Transport.

ACS nano·2026
Same author

NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1<sup>+</sup> smooth muscle cells in atherosclerotic lesions.

Atherosclerosis·2026
Same author

Sociodemographic Factors and Mental Distress as Determinants of Perceived Noise Pollution in Four European Regions.

Noise & health·2026
Same author

Methodological considerations in the analysis of survival data in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Platelet-specific TGFβ Deficiency Aggravates Atherosclerosis, Vascular Inflammation, and Hypercholesterolemia in Mice.

Thrombosis and haemostasis·2025
Same author

Psychosocial moderators of the effect of lifestyle interventions in primary prevention of cardiovascular disease: a scoping review.

BMC public health·2025

Related Experiment Video

Updated: Jun 21, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

Adaptive immunity and atherosclerosis.

John Andersson1, Peter Libby, Göran K Hansson

  • 1Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm SE-17176, Sweden. john.andersson@ki.se

Clinical Immunology (Orlando, Fla.)
|July 29, 2009
PubMed
Summary

Adaptive immunity, particularly T cells, significantly impacts atherosclerosis development and lesion stability. Understanding T cell roles offers new strategies for treating this common cause of death.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

Related Experiment Videos

Last Updated: Jun 21, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Pathophysiology

Background:

  • Atherosclerosis is a leading global cause of mortality, characterized by inflammatory arterial lesions.
  • The role of adaptive immunity, especially T cells, in regulating inflammation and lesion progression in atherosclerosis has been recognized for over two decades.

Purpose of the Study:

  • To review the current understanding of T cell involvement in atherogenesis.
  • To explore T cell antigen recognition, costimulation/coinhibition, and mediator secretion in the context of atherosclerosis.
  • To identify future research directions and potential clinical interventions targeting T cells.

Main Methods:

  • Literature review of existing research on T cells and atherosclerosis.
  • Synthesis of current knowledge on T cell subsets, activation pathways, and effector functions in atherogenesis.
  • Analysis of the impact of T cell-mediated immunity on atherosclerotic lesion stability and clinical outcomes.

Main Results:

  • T cells are crucial regulators of the pro-inflammatory response in atherosclerosis.
  • T cell activity influences atherosclerotic plaque stability, thrombus formation, and disease prognosis.
  • Specific T cell antigens, costimulatory/coinhibitory signals, and secreted mediators play key roles.

Conclusions:

  • T cells are central players in the pathogenesis and progression of atherosclerosis.
  • Further research into T cell mechanisms can uncover novel therapeutic targets.
  • Modulating T cell responses holds promise for future clinical interventions in atherosclerosis management.